Ablative Therapies in Low-Risk Thyroid Cancer

Area of Science:

• Endocrinology
• Surgical Oncology
• Interventional Radiology

Background:

• Thyroid cancer treatment has shifted towards less invasive approaches over the past 20 years.
• Partial thyroidectomy and active surveillance are increasingly common for low-risk thyroid cancer.
• Percutaneous ablation is established for benign thyroid nodules, prompting interest in its oncologic application.

Purpose of the Study:

• To review percutaneous ablative therapies for low-risk thyroid cancer.
• To summarize current evidence on the efficacy and safety of these techniques.
• To identify knowledge gaps and propose clinical practice recommendations.

Main Methods:

• Review of contemporary literature on percutaneous ablation modalities for thyroid cancer.
• Analysis of evidence regarding treatment outcomes, including efficacy and safety.
• Synthesis of findings to inform clinical practice and future research.

Main Results:

• Percutaneous ablation is emerging as a viable intermediate treatment option for select low-risk thyroid cancers.
• Evidence supports its potential as an alternative to surgery or surveillance in carefully selected patients.
• Further research is needed to establish standardized protocols and long-term outcomes.

Conclusions:

• Percutaneous ablation represents a significant advancement in the de-escalation of thyroid cancer treatment.
• Real-world practice recommendations are proposed to guide the application of these techniques.
• Continued investigation is crucial for optimizing the role of ablation in thyroid cancer management.